Item Type | Name |
Concept
|
Gastroenterology
|
Academic Article
|
Activation of the hepatocarcinogen aflatoxin B1 by forms of human hepatic cytochromes P-450: some do and some don't.
|
Academic Article
|
Antibodies against mitochondrial dehydrogenase complexes in primary biliary cirrhosis.
|
Academic Article
|
Prevalence and prediction of osteopenia in chronic liver disease.
|
Academic Article
|
Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease.
|
Academic Article
|
Choline may be an essential nutrient in malnourished patients with cirrhosis.
|
Academic Article
|
Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells.
|
Academic Article
|
Hepatic microsomal function in rats with chronic dietary iron overload.
|
Academic Article
|
Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function.
|
Academic Article
|
Hepatic heme synthesis in a new model of experimental hemochromatosis: studies in rats fed finely divided elemental iron.
|
Academic Article
|
Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defect.
|
Academic Article
|
Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phenobarbital.
|
Academic Article
|
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
|
Academic Article
|
Putting the freeze on hepatitis C virus-associated mixed cryoglobulinemia.
|
Academic Article
|
Effects of hemopexin on heme-mediated repression of 5-aminolevulinate synthase and induction of heme oxygenase in cultured hepatocytes.
|
Academic Article
|
Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency.
|
Academic Article
|
Nutritional supplementation in chronic liver disease: an analytical review.
|
Academic Article
|
Repression of hepatic delta-aminolevulinate synthase by heme and metalloporphyrins: relationship to inhibition of heme oxygenase.
|
Academic Article
|
Advances in understanding and treating 'the little imitator,' acute porphyria.
|
Academic Article
|
An update on iron metabolism: summary of the Fifth International Conference on Disorders of Iron Metabolism.
|
Academic Article
|
Iron and chronic viral hepatitis.
|
Academic Article
|
Therapy of hepatitis C: other options.
|
Academic Article
|
Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study.
|
Academic Article
|
Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
|
Academic Article
|
Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C.
|
Academic Article
|
Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.
|
Academic Article
|
Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats.
|
Academic Article
|
Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
|
Academic Article
|
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
|
Academic Article
|
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
|
Academic Article
|
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C.
|
Academic Article
|
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.
|
Academic Article
|
No role of the -2518 promoter polymorphism of monocyte chemotactic protein-1 in chronic hepatitis C.
|
Academic Article
|
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
|
Academic Article
|
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
|
Academic Article
|
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
|
Academic Article
|
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
|
Academic Article
|
Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes.
|
Academic Article
|
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
|
Academic Article
|
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
|
Academic Article
|
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
|
Academic Article
|
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.
|
Academic Article
|
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
|
Academic Article
|
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
|
Academic Article
|
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
|
Academic Article
|
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.
|
Academic Article
|
Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial.
|
Academic Article
|
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
|
Academic Article
|
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.
|
Academic Article
|
Zinc mesoporphyrin induces rapid proteasomal degradation of hepatitis C nonstructural 5A protein in human hepatoma cells.
|
Academic Article
|
Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review.
|
Academic Article
|
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Academic Article
|
MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins.
|
Academic Article
|
Genetic variations in heme oxygenase-1 and chronic hepatitis.
|
Academic Article
|
Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
|
Academic Article
|
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis.
|
Academic Article
|
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
|
Academic Article
|
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.
|
Academic Article
|
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
|
Academic Article
|
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
|
Academic Article
|
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
|
Academic Article
|
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
|
Academic Article
|
Novel role of nuclear receptor Rev-erba in hepatic stellate cell activation: potential therapeutic target for liver injury.
|
Academic Article
|
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
|
Academic Article
|
Indications for liver transplant and AASLD guidelines.
|
Academic Article
|
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
|
Academic Article
|
Herbal dietary supplement associated hepatotoxicity: an upcoming workshop and need for research.
|
Academic Article
|
Herbal products and the liver: a review of adverse effects and mechanisms.
|
Academic Article
|
On stress and the liver: a chicken and egg conundrum.
|
Academic Article
|
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
|
Academic Article
|
Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.
|
Academic Article
|
Acute hepatic porphyrias: Recommendations for evaluation and long-term management.
|
Academic Article
|
Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.
|
Academic Article
|
Reply.
|
Academic Article
|
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks.
|
Academic Article
|
Hepatocellular Carcinoma in Acute Hepatic Porphyrias: Results from the Longitudinal Study of the U.S. Porphyrias Consortium.
|
Academic Article
|
HLA-B*35:01 and Green Tea-Induced Liver Injury.
|